Connection

Evangelos Terpos to Cardiotoxicity

This is a "connection" page, showing publications Evangelos Terpos has written about Cardiotoxicity.
Connection Strength

0.655
  1. Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin. Blood. 2019 02 14; 133(7):710-723.
    View in: PubMed
    Score: 0.585
  2. Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA). Haematologica. 2018 09; 103(9):1422-1432.
    View in: PubMed
    Score: 0.036
  3. Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events. Sci Rep. 2017 12 19; 7(1):17802.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.